$ALDX News Article - Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 2 Clinical Trial of ADX-2191 in Patients with Retinitis Pigmentosa https://marketwirenews.com/news-releases/alde...55701.html
(0)
(0)
Aldeyra Therapeutics Inc. (ALDX) Stock Research Links